NCT04855279

Brief Summary

This study aims to evaluate the use of different desensitizing agents before in-office bleaching. A total of 64 volunteers were randomly divided into four groups. Before undergoing in-office bleaching with 38% hydrogen peroxide gel (three applications of 15 minutes each, one session), clinicians applied a placebo gel (control group), casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), neutral sodium fluoride gel (NSF), or nano-hydroxyapatite solution (n-HAP) on all buccal surfaces of teeth. The gel was left undisturbed for 4 minutes. Patients recorded their tooth sensitivities on the VAS scale. Kruskal-Wallis test followed by Mann-Whitney U test were used to compare changes in tooth color and intensity of tooth sensitivity between groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 7, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2019

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2019

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

April 19, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 22, 2021

Completed
Last Updated

April 28, 2021

Status Verified

April 1, 2021

Enrollment Period

6 months

First QC Date

April 19, 2021

Last Update Submit

April 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effect of reducing hypersensitivity after bleaching

    VAS scale (Visual Analog Scale) was measured before and after bleaching

    1 week

Study Arms (4)

Control

PLACEBO COMPARATOR
Other: glycerine

Topical neutral sodium fluoride

ACTIVE COMPARATOR
Other: neutral sodium fluoride

ACP-CCP gel

ACTIVE COMPARATOR
Other: ACP-CCP gel

nano-hydroxyapatite solution

ACTIVE COMPARATOR
Other: nano-hydroxyapatite solution

Interventions

Topically applied

Topical neutral sodium fluoride

Topically applied

ACP-CCP gel

Topically applied

nano-hydroxyapatite solution

Topically applied

Control

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Must have all their upper and lower anterior teeth
  • Must have good oral hygiene

You may not qualify if:

  • Pregnancy or breastfeeding
  • Systemic disease
  • Taking NSAIDs or other drug treatment.
  • Periodontal disease
  • Enamel hypoplasia
  • Teeth stained by tetracycline or fluorosis
  • Dental malposition or orthodontic treatment with fixed appliances
  • Canine teeth lighter than A1
  • Restoration on anterior teeth
  • Cervical lesions
  • Symptoms of dental pain
  • Previous tooth whitening experience.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medipol Mega University Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Reis A, Dalanhol AP, Cunha TS, Kossatz S, Loguercio AD. Assessment of tooth sensitivity using a desensitizer before light-activated bleaching. Oper Dent. 2011 Jan-Feb;36(1):12-7. doi: 10.2341/10-148-CR. Epub 2011 Mar 24.

    PMID: 21488723BACKGROUND

MeSH Terms

Conditions

Dentin Sensitivity

Interventions

Glycerol

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Triose Sugar AlcoholsSugar AlcoholsAlcoholsOrganic ChemicalsCarbohydrates

Study Officials

  • Benin Dikmen, Dr.

    Medipol University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist. Prof. Dr.

Study Record Dates

First Submitted

April 19, 2021

First Posted

April 22, 2021

Study Start

January 7, 2019

Primary Completion

June 28, 2019

Study Completion

July 26, 2019

Last Updated

April 28, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations